NeptuneMedical Raises $97M in Funding to Revolutionize Medical Device Innovation

Neptune Medical, an innovative venture capital-funded medical device start-up based in Burlingame, California, is proud to announce a significant funding milestone. The company has successfully raised $97 million to propel its ambitious vision of transforming healthcare through breakthrough medical technologies. Specializing in high-volume and clinically impactful devices, Neptune Medical focuses primarily on the gastroenterology sector while also pioneering advancements that will affect multiple medical disciplines, including cardiovascular, pulmonary, and neuro. At the heart of the company's product development is their patent-pending Dynamic Rigidization™ technology, which allows thin-walled tubes—such as catheters and cannulae—to toggle instantly between flexible and rigid states. This remarkable capability enhances both access and control deep within the human body, opening new avenues for treatment that were previously deemed challenging or impossible. The newly acquired funds will primarily be used to accelerate the development of their Triton Medical Robotics division, where flexible robotic systems are being innovated to address urgent unmet medical needs across various indications. Additionally, the investment will support further research and expansion initiatives aimed at scaling production and market entry. With a robust team of approximately 50 industry experts, comprising serially successful medical device entrepreneurs, Neptune Medical is poised to make a substantial impact on the healthcare landscape over the next several years. As the company continues to innovate and evolve, it remains committed to improving patient outcomes through the power of cutting-edge technology. For more information, please visit our website below.